Published in World J Hepatol on July 27, 2014
Liver-Tumor Hybrid Organoids for Modeling Tumor Growth and Drug Response In Vitro. Ann Biomed Eng (2015) 0.79
Predictors of recurrence after a first hepatectomy for colorectal cancer liver metastases: a retrospective analysis. World J Surg Oncol (2014) 0.76
Global cancer statistics, 2002. CA Cancer J Clin (2005) 119.22
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med (2004) 49.02
Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg (1999) 14.31
Cetuximab for the treatment of colorectal cancer. N Engl J Med (2007) 13.39
Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA (2010) 10.97
Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer. J Clin Oncol (2003) 8.95
Resection of colorectal liver metastases. World J Surg (1995) 7.73
Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med (1999) 7.04
Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg (2004) 6.75
Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg (2002) 6.24
Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg (2004) 5.10
Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial. Lancet (2007) 4.68
Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial. J Clin Oncol (2006) 4.42
Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg (1996) 4.41
Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg (1990) 4.36
Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial. Lancet (2007) 3.85
Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Ann Surg (2004) 3.72
Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol (2009) 3.66
Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials. J Clin Oncol (2008) 3.49
Complications of radiofrequency coagulation of liver tumours. Br J Surg (2002) 3.39
Experience with more than 500 minimally invasive hepatic procedures. Ann Surg (2008) 3.23
Meta-analysis of hepatic arterial infusion for unresectable liver metastases from colorectal cancer: the end of an era? J Clin Oncol (2007) 3.15
Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients. Ann Surg (2009) 3.15
Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg (2006) 3.05
Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg (2000) 2.92
Resection of hepatic metastases from colorectal cancer. Biologic perspective. Ann Surg (1989) 2.79
Selection of patients for resection of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol (2006) 2.66
Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg (2004) 2.65
Advanced colorectal cancer: ESMO Clinical Practice Guidelines for treatment. Ann Oncol (2010) 2.54
American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer. J Clin Oncol (2009) 2.52
Implications for KRAS status and EGFR-targeted therapies in metastatic CRC. Nat Rev Clin Oncol (2009) 2.48
Radiofrequency versus microwave ablation in a hepatic porcine model. Radiology (2005) 2.38
Guidelines for resection of colorectal cancer liver metastases. Gut (2006) 2.35
Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). J Clin Oncol (2006) 2.29
Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: an updated meta-analysis. J Clin Oncol (2004) 2.24
Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system. J Am Coll Surg (1999) 2.22
Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. Ann Oncol (2001) 2.20
Pathologic response and microdosimetry of (90)Y microspheres in man: review of four explanted whole livers. Int J Radiat Oncol Biol Phys (2004) 2.11
Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome. Ann Surg (1998) 2.10
Clinical short-term results of radiofrequency ablation in liver cancers. World J Gastroenterol (2002) 2.04
Safety and efficacy of microwave ablation of hepatic tumors: a prospective review of a 5-year experience. Ann Surg Oncol (2009) 1.97
Pancreatic or liver resection for malignancy is safe and effective for the elderly. Ann Surg (1995) 1.91
Stereotactic body radiotherapy for colorectal liver metastases: a pooled analysis. Cancer (2011) 1.87
A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer. Ann Oncol (2009) 1.81
Therapeutic results for hepatic metastasis of colorectal cancer with special reference to effectiveness of hepatectomy: analysis of prognostic factors for 763 cases recorded at 18 institutions. Dis Colon Rectum (2003) 1.60
Selection for hepatic resection of colorectal liver metastases: expert consensus statement. HPB (Oxford) (2013) 1.50
Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma. J Clin Oncol (2009) 1.50
Repeat curative intent liver surgery is safe and effective for recurrent colorectal liver metastasis: results from an international multi-institutional analysis. J Gastrointest Surg (2009) 1.41
Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases. Br J Cancer (2010) 1.39
Stereotactic body radiation therapy for colorectal liver metastases. Br J Surg (2010) 1.35
Hepatic tumor ablation with clustered microwave antennae: the US Phase II trial. HPB (Oxford) (2007) 1.33
Downstaging of hepatocellular carcinoma and liver metastases from colorectal cancer by selective intra-arterial chemotherapy. Surgery (2002) 1.29
A collective review of the world literature on hepatic cryotherapy. J R Coll Surg Edinb (1998) 1.26
Prognostic scoring in colorectal cancer liver metastases: development and validation. Arch Surg (2005) 1.26
World survey on the complications of hepatic and prostate cryotherapy. World J Surg (1999) 1.25
Staged or simultaneous resection of synchronous liver metastases from colorectal cancer--a systematic review. Colorectal Dis (2008) 1.24
A systematic review on the clinical benefit and role of radiofrequency ablation as treatment of colorectal liver metastases. Eur J Cancer (2009) 1.23
Intra-arterial infusion of irinotecan-loaded drug-eluting beads (DEBIRI) versus intravenous therapy (FOLFIRI) for hepatic metastases from colorectal cancer: final results of a phase III study. Anticancer Res (2012) 1.22
The blood supply of experimental liver metastases. IV. Changes in vascularity with increasing tumor growth. Surgery (1974) 1.22
A comparative histological evaluation of the ablations produced by microwave, cryotherapy and radiofrequency in the liver. Pathology (2009) 1.20
Ablative therapies for colorectal liver metastases: a systematic review. Colorectal Dis (2011) 1.18
Systematic review of randomized and nonrandomized trials of the clinical response and outcomes of neoadjuvant systemic chemotherapy for resectable colorectal liver metastases. Ann Surg Oncol (2009) 1.14
Combination of neoadjuvant chemotherapy with cryotherapy and surgical resection for the treatment of unresectable liver metastases from colorectal carcinoma. Cancer (2002) 1.14
Prospective evaluation of the impact of [18F]fluoro-2-deoxy-D-glucose positron emission tomography of resectable colorectal liver metastases. Br J Surg (2005) 1.09
Treatment of liver colorectal metastases: role of laparoscopy, radiofrequency ablation, and microwave coagulation. J Surg Oncol (2010) 1.08
Locoregional surgical and interventional therapies for advanced colorectal cancer liver metastases: expert consensus statements. HPB (Oxford) (2013) 1.08
(18)F-DG PET/CT in detection of recurrence and metastasis of colorectal cancer. World J Gastroenterol (2007) 1.07
Laparoscopic liver resection: experience of 53 procedures at a single center. J Hepatobiliary Pancreat Surg (2005) 1.07
Systemic cytotoxic and biological therapies of colorectal liver metastases: expert consensus statement. HPB (Oxford) (2012) 1.07
Surgical treatment of hepatic colorectal metastasis: evolving role in the setting of improving systemic therapies and ablative treatments in the 21st century. Cancer J (2010) 1.06
Response to neoadjuvant chemotherapy does not predict overall survival for patients with synchronous colorectal hepatic metastases. Ann Surg Oncol (2009) 1.04
Whole-body MRI at 1.5 T and 3 T compared with FDG-PET-CT for the detection of tumour recurrence in patients with colorectal cancer. Eur Radiol (2009) 1.02
Tumor and liver drug uptake following hepatic artery and portal vein infusion. J Clin Oncol (1987) 1.01
Treatment of colorectal metastases: surgery, cryotherapy, or radiofrequency ablation. Gut (2002) 1.01
90Y microsphere (TheraSphere) treatment for unresectable colorectal cancer metastases of the liver: response to treatment at targeted doses of 135-150 Gy as measured by [18F]fluorodeoxyglucose positron emission tomography and computed tomographic imaging. J Vasc Interv Radiol (2005) 1.01
The management of variant arterial anatomy during hepatic arterial infusion pump placement. Ann Surg Oncol (2002) 1.00
Timing of multimodality therapy for resectable synchronous colorectal liver metastases: a retrospective multi-institutional analysis. Ann Surg Oncol (2008) 0.99
Phase I study of hepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer. J Clin Oncol (2001) 0.99
Surgical downstaging and neo-adjuvant therapy in metastatic colorectal carcinoma with irinotecan drug-eluting beads: a multi-institutional study. HPB (Oxford) (2010) 0.97
Colorectal liver metastases. Int J Surg Oncol (2011) 0.93
Intrahepatic arterial infusion of chemotherapy: pharmacologic principles. Semin Oncol (2002) 0.92
Modern hepatic imaging. Surg Clin North Am (2004) 0.91
Yttrium-90 microsphere-selective internal radiation therapy with chemotherapy (chemo-SIRT) for colorectal cancer liver metastases: an in vivo double-arm-controlled phase II trial. Am J Clin Oncol (2013) 0.89
A marking technique for intraoperative localization of small liver metastases before systemic chemotherapy. Ann Surg Oncol (2009) 0.89
Transarterial chemoembolization with irinotecan beads in the treatment of colorectal liver metastases: systematic review. J Vasc Interv Radiol (2013) 0.87
Comparison of the effects of in-vivo thermal ablation of pig liver by microwave and radiofrequency coagulation. J Hepatobiliary Pancreat Surg (2000) 0.87
Liver resection for primarily unresectable colorectal metastases downsized by chemotherapy. J Gastrointest Surg (2007) 0.87
Radiofrequency ablation as a treatment tool for liver metastases of colorectal origin. Cancer Imaging (2011) 0.86
Irinotecan drug-eluting beads in the treatment of chemo-naive unresectable colorectal liver metastasis with concomitant systemic fluorouracil and oxaliplatin: results of pharmacokinetics and phase I trial. J Gastrointest Surg (2012) 0.86
Hepatic arterial floxuridine and leucovorin for unresectable liver metastases from colorectal carcinoma. New dose schedules and survival update. Cancer (1994) 0.85
Locoregional therapy for liver metastases from colorectal cancer: the possibilities of intraarterial chemotherapy, and new hepatic-directed modalities. Hepatogastroenterology (2001) 0.83
Surgical management of colorectal liver metastases. Clin Colon Rectal Surg (2009) 0.82
Recent advances in CT imaging of liver metastases. Cancer J (2004) 0.82
Integrating radioembolization with chemotherapy in the treatment paradigm for unresectable colorectal liver metastases. Am J Clin Oncol (2012) 0.81
Liver resection or cryotherapy for colorectal liver metastases: a prospective case control study. Int J Colorectal Dis (2005) 0.80
Two decades of experience with hepatic cryotherapy for advanced colorectal metastases. Ann Surg Oncol (2011) 0.78